Physician Assistant in Dumfries, VA Accepting Medicare

6 Physician Assistant nurses found. Showing 1 - 6

Stephanie J Navas, PA Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 3990 Fettler Park Dr, Dumfries, VA 22025 Phone: 703-445-8312

Tenbit Afework, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 3928 Lansing Ct, Dumfries, VA 22026 Phone: 703-221-2109

Brooke M. Schmerfeld, PA-C, M.S. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3990 Fettler Park Dr, Dumfries, VA 22025 Phone: 703-445-8312

Maria Elena Claros, PA Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 17739 Main St Ste 130, Dumfries, VA 22026 Phone: 703-680-7950

Sydney Van Dellen, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 16830 Dumfries Rd, Ste 160, Dumfries, VA 22025 Phone: 703-523-1750    Fax: 844-518-0708

Colleen Michelle Class, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 16608 Accolon Ct, Dumfries, VA 22025 Phone: 703-216-1755

News Archive

FDA approves NDA for Edgemont's Fluoxetine 60 mg tablet

Edgemont Pharmaceuticals, LLC, a neuroscience focused company, today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Fluoxetine Tablets 60 mg.

Deadly parasite could potentially be used to treat various types of cancers

Scientists have discovered that a deadly parasite, known to cause ill health in pregnant women and immunocompromised patients, could potentially be used to treat various types of tumors.

Hormonal contraceptives increase risk of HSV-2 transmission

Women who are infected with herpes simplex virus type 2 (HSV-2) may have an increased risk of transmitting the virus to others if they use hormonal contraceptives or have certain bacterial vaginal infections, according to an article in the May 15 issue of Clinical Infectious Diseases, now available online.

University of Zurich receives AICR grant to improve vaccines against Burkitt's lymphoma

Research in Switzerland could help reduce the time taken to develop vaccines against cancer tumours.

Unavailability of Avastin more dangerous risk for breast cancer patients, says FAMEDS founder

Breast cancer patients and their families will rally together on Tuesday, June 28, at 7:00 am outside of the Federal Drug Administration (FDA). At issue will be the FDA's final hearing to remove the anti-cancer drug Avastin from the approved medication list for treatment of late stage breast cancer, despite the FDA approving it in 2008 for use to treat breast cancer.

Read more Medical News

› Verified 1 days ago